Pharmagreen
  • HOME

  • More

    Use tab to navigate through the menu items.
    Pharmagreen Biotech Aims to Update Its Shareholders on Company Focus on CBD Hemp Industry

    Pharmagreen Biotech Aims to Update Its Shareholders on Company Focus on CBD Hemp Industry

    CARSON CITY, NV, Jan. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc. (OTC: PHBI), a company specializing in the development of high quality tissue cultured starter plantlets, CBD oils, formulations and isolates from hemp plants announced today that we are changing our emphasis to targeting hemp and the CBD industry. “After taking much time to carefully analyze our strategic options, we have decided that immediate business development in the hemp in
    Pharmagreen Issues Statement on Exiting the Chapter 11 Process Press Release | 10/19/2020

    Pharmagreen Issues Statement on Exiting the Chapter 11 Process Press Release | 10/19/2020

    CARSON CITY, NV, Oct. 19, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), a company specializing in the development of tissue cultured starter plantlets for the hemp industry, today announced that it is no longer under chapter 11 proceedings of the U.S. Bankruptcy Code. On August 11, 2020, the Company voluntarily filed for petitions for relief under chapter 11. On October 09, 2020, a stay order was lifted by a United States District

    © 2022 ALL RIGHTS RESERVED PHARMAGREEN BIOTECH INC.